Victory Pharma Announces $45 Million Equity Financing
“We are delighted to have
Mr. Barry remarked, “Essex is excited to invest in such an experienced and successful management team which has demonstrated an ability to execute commercially with the Company’s lead product NAPRELAN(R) and at prior companies. Victory is a rapidly growing, profitable business that we see as an excellent growth equity platform upon which to build a substantial specialty pharmaceutical company.”
Cowen and Company, LLC acted as exclusive placement agent for the transaction.
About Victory Pharma
Founded in 2003, Victory Pharma, Inc. is a privately held specialty pharmaceutical company headquartered in
NAPRELAN(R) is a trademark of Elan Corporation, plc.
SOURCE Victory Pharma, Inc.